Theratechnologies Inc (NASDAQ:THTX)

2.11
Delayed Data
As of Jul 06
 -0.03 / -1.40%
Today’s Change
2.05
Today|||52-Week Range
4.46
-30.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$200.7M

Company Description

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.

Contact Information

Theratechnologies, Inc.
2015 Peel Street
Montréal Qubec H3A 1T8
P:(514) 336-7800
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Paul LévesquePresident, Chief Executive Officer & Director
Philippe DubucChief Financial Officer & Senior Vice President
Christian MarsolaisChief Medical Officer & Senior Vice President
Marie-Noël ColussiVice President-Finance
John LeasureGlobal Commercial Officer